Eli Lilly and Company
Long

US FDA approves Jardiance® (empagliflozin) to treat adults with

54
LLY: Eli Lilly and Company
2022-02-24 16:00:00
US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.